On March 22, 2004, the Food and Drug Administration (FDA) issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at the beginning of treatment, or when the doses are changed with either an increase or decrease in the dose. Read More
Comments
No comments yet. Leave a Comment

